Atıf Formatları
Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Cimen Et Al. , "Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease," 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , vol.273, İstanbul, Turkey, pp.209, 2006

Cimen, B. Et Al. 2006. Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease. 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , (İstanbul, Turkey), 209.

Cimen, B., Gelisgen, R., Andican, G., Yumuk, V., Bolayirli, M., Hacibekiroglu, M., ... Burcak, G.(2006). Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease . 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) (pp.209). İstanbul, Turkey

Cimen, B. Et Al. "Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease," 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 2006

Cimen, B. Et Al. "Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease." 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , İstanbul, Turkey, pp.209, 2006

Cimen, B. Et Al. (2006) . "Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease." 31st Congress of the Federation-of-European-Biochemical-Societies (FEBS) , İstanbul, Turkey, p.209.

@conferencepaper{conferencepaper, author={B. Cimen Et Al. }, title={Advanced glycation end products in type 2 diabetes patients with and without coronary artery disease}, congress name={31st Congress of the Federation-of-European-Biochemical-Societies (FEBS)}, city={İstanbul}, country={Turkey}, year={2006}, pages={209} }